Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. (Q44425255)
Jump to navigation
Jump to search
scientific article published on 4 June 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. |
scientific article published on 4 June 2012 |
Statements
Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers (English)
S M Sengsayadeth
M Jagasia
B G Engelhardt
A Kassim
S Goodman
C Lucid
C L Vnencak-Jones
J P Greer
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference